Capitol Hill Briefing: Personalized Medicine and Responsible Access to Pain Medication

Personalized Medicine and Responsible Access to Pain Medication:
A Capitol Hill Briefing

AGENDA

10AM: Welcome

            Peter Pitts, Center for Medicine in the Public Interest

11:00: Access to Pain Medications: The Role of Patients and Manufacturers
            Moderator: Steve Usdin, BioCentury
            Cindy Steinberg, US Pain Foundation
            Bob Twillman, American Academy of Pain Management
            Stuart Kim, Mallinckrodt Pharmaceuticals

12:00: Issue: Pain Medications: Two Reporters Views

            Moderator: Peter Pitts, CMPI
            Steve Usdin, BioCentury
            Judy Foreman, Syndicated Columnist

1:30:    Closing Keynote: Pain Medications and the Future of Personalized       Medicine

            Introduction: Peter Pitts, CMPI
            Charles Inturrisi, Weill Cornell Medical Center

2:15: Closing Remarks

Peter Pitts, Center for Medicine in the Public Interest

The coronavirus could help pharma reset its reputation in Washington

The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington.... Read more

STAT
10/17/2024 12:00 AM

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Differing philosophies within and outside of government could doom the hub... Read more

The Washington Times
07/02/2024 12:00 AM

Tort bar’s newest collateral damage: Preterm babies

Lawsuits allege links between intestinal disease, infant formula and human milk fortifiers... Read more

Capitol Hill Briefing: Personalized Medicine and Responsible Access to Pain Medication

RECENT NEWS

The coronavirus could help pharma reset its reputation in Washington

The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Tort bar’s newest collateral damage: Preterm babies

DRUGWONKS BLOG

RESEARCH ISSUES